reports
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.
Biosynex Completes Acquisition of Chembio Diagnostics, Inc. Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced it has completed its acquisition of Chembio Diagnostics, Inc. (“Chembio”), a leading point-of-care diagnostics company focused on infectious diseases. Chembio is now part of Biosynex Group. The complementary nature of the technologi...
- Jonathan Moreland
SFBS SERVISFIRST BANCSHARES INC
HEAR TURTLE BEACH CORP
GBCI GLACIER BANCORP INC.
CTBI COMMUNITY TRUST BANCORP INC.
CEMI CHEMBIO DIAGNOSTICS INC.
AVAV AEROVIRONMENT INC.
INVE INDENTIV
NKSH NATIONAL BANKSHARES INC.
SCWX SECUREWORKS
GNTY GUARANTY BANCSHARES INC.
BCBP BCB BANCORP INC.
- Jonathan Moreland
HPP HUDSON PACIFIC PROPERTIES INC.
TLYS TILLYS
SFE SAFEGUARD SCIENTIFICS INC.
SFBS SERVISFIRST BANCSHARES INC
PRTK PARATEK PHARMACEUTICALS INC
KSS KOHL'S CORPORATION
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CEMI CHEMBIO DIAGNOSTICS INC.
AVAV AEROVIRONMENT INC.
ALOT ASTRONOVA INC.
SCWX SECUREWORKS
MRUS MERUS B V
OCX ONCOCYTE
WDFC WD-40 COMPANY
BRN BARNWELL INDUSTRIES
VBIV VBI VACCINES INC/BC
BLNK BLINK CHARGING
CSSE CHICKEN SOUP FOR THE SOUL ENTERTAINMENT INC
PRPL PURPLE INNOVATION
DOMO INC.
ONCT DOMO INCORPORATED
SDC ONCTERNAL THERAPEUTICS INC
PCB SMILEDIRECTCLUB
ALTG INC.
PHAT PACIFIC CITY FINANCIAL CORP
ENX ALTA EQUIPMENT GROUP INC.
U PHATHOM PHARMACEUTICALS
INZY EATON VANCE NEW YORK MUNICIPAL BOND FUND
PUBM UNITY SOFTWARE INC.
FOA INOZYME PHARMA
RMBL PUBMATIC
AFBI FINANCE OF AMERICA COMPANIES INC.
FYBR RUMBLEON INC
ERAS AFFINITY BANCSHARES
APLD INC.
GLSI FRONTIER COMMUNICATIONS PARENT
MIRO INC.
SLG ERASCA INC
COCP APPLIED BLOCKCHAIN INC
GREENWICH LIFESCIENCES INC
MIROMATRIX MEDICAL INC
SL GREEN REALTY CORP.
COCRYSTAL PHARMA INC
- Jonathan Moreland
Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York...
Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023 Failure to tender shares could result in the termination of the proposed merger between Chembio and Biosynex MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 Fellow Chembio Stockholders, We strongly urge you to tender your shares of common stock ...
- Jonathan Moreland
- Jonathan Moreland
TLYS TILLYS
SFE SAFEGUARD SCIENTIFICS INC.
PRTK PARATEK PHARMACEUTICALS INC
KSS KOHL'S CORPORATION
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CEMI CHEMBIO DIAGNOSTICS INC.
AVAV AEROVIRONMENT INC.
UHAL AMERCO
UNFI UNITED NATURAL FOODS INC.
ALOT ASTRONOVA INC.
MRUS MERUS B V
OCX ONCOCYTE
WDFC WD-40 COMPANY
BRN BARNWELL INDUSTRIES
VBIV VBI VACCINES INC/BC
BLNK BLINK CHARGING
CSSE CHICKEN SOUP FOR THE SOUL ENTERTAINMENT INC
PRPL PURPLE INNOVATION
DOMO INC.
HHC DOMO INCORPORATED
SDC THE HOWARD HUGHES CORPORATION
ALIM SMILEDIRECTCLUB
PCB INC.
ALTG ALIMERA SCIENCES
PHAT PACIFIC CITY FINANCIAL CORP
ENX ALTA EQUIPMENT GROUP INC.
U PHATHOM PHARMACEUTICALS
INZY EATON VANCE NEW YORK MUNICIPAL BOND FUND
PRAX UNITY SOFTWARE INC.
PUBM INOZYME PHARMA
FOA PRAXIS PRECISION MEDICINES
RMBL PUBMATIC
AFBI FINANCE OF AMERICA COMPANIES INC.
ERAS RUMBLEON INC
APLD AFFINITY BANCSHARES
GLSI INC.
MIRO ERASCA INC
SLG APPLIED BLOCKCHAIN INC
COCP GREENWICH LIFESCIENCES INC
MIROMATRIX MEDICAL INC
SL GREEN REALTY CORP.
COCRYSTAL PHARMA INC
- Jonathan Moreland
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, I...
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc. STRASBOURG, France, April 13, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced that Project Merci Merger Sub, Inc. (“Purchaser”), a Nevada corporation and its wholly-owned indirect subsidiary, has extended the expiration time for the previously announced tender offer to purchase all of the issued and outstanding shares of common stock (the “Shares”) of Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”)...
Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New Y...
Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023 MEDFORD, N.Y., April 10, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 10, 2023 Fellow Chembio Stockholders, As previously communicated, Chembio Diagnostics, Inc. (“Chembio” or the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of January...
- Jonathan Moreland
VNOM VIPER ENERGY PARTNERS LP
TLYS TILLYS
SF STIFEL FINANCIAL CORP.
PRTK PARATEK PHARMACEUTICALS INC
PFSW PFSWEB INC
LPCN LIPOCINE INC
KSS KOHL'S CORPORATION
DLTR DOLLAR TREE INC.
DG DOLLAR GENERAL CORPORATION
CVGW CALAVO GROWERS INC.
CEMI CHEMBIO DIAGNOSTICS INC.
AVAV AEROVIRONMENT INC.
APEI AMERICAN PUBLIC EDUCATION
AEL AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
BFS SAUL CENTERS INC.
CIVB CIVISTA BANCSHARES
UHAL AMERCO
UNFI UNITED NATURAL FOODS INC.
SCWX SECUREWORKS
OCX ONCOCYTE
BRN BARNWELL INDUSTRIES
VBIV VBI VACCINES INC/BC
BLNK BLINK CHARGING
CSSE CHICKEN SOUP FOR THE SOUL ENTERTAINMENT INC
PRPL PURPLE INNOVATION
HHC INC.
SDC THE HOWARD HUGHES CORPORATION
ALIM SMILEDIRECTCLUB
PCB INC.
ALTG ALIMERA SCIENCES
ENX PACIFIC CITY FINANCIAL CORP
U ALTA EQUIPMENT GROUP INC.
INZY EATON VANCE NEW YORK MUNICIPAL BOND FUND
PRAX UNITY SOFTWARE INC.
PUBM INOZYME PHARMA
AMWL PRAXIS PRECISION MEDICINES
FOA PUBMATIC
AFBI AMERICAN WELL
ERAS FINANCE OF AMERICA COMPANIES INC.
MIRO AFFINITY BANCSHARES
SLG INC.
COCP ERASCA INC
MIROMATRIX MEDICAL INC
SL GREEN REALTY CORP.
COCRYSTAL PHARMA INC
- Jonathan Moreland
Chembio’s CEO Letter to Stockholders
Chembio’s CEO Letter to Stockholders Reminder to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023 MEDFORD, N.Y., April 03, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 3, 2023 Fellow Chembio Stockholders, As previously communicated, Chembio Diagnostics, Inc. (“Chembio” or the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), da...
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, I...
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc. STRASBOURG, France, March 29, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced that Project Merci Merger Sub, Inc. (“Purchaser”), a Nevada corporation and its wholly-owned indirect subsidiary, has extended the expiration time for the previously announced tender offer to purchase all of the issued and outstanding shares of common stock (the “Shares”) of Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”)...
Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York...
Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023 MEDFORD, N.Y., March 21, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. Fellow Chembio Stockholders, As previously disclosed, Chembio Diagnostics, Inc. (“Chembio” or the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of January 31, 2023, with Biosyn...
Chembio Announces Letter to Stockholders Regarding Tender Offer
Chembio Announces Letter to Stockholders Regarding Tender Offer MEDFORD, N.Y., March 15, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. March 15, 2023 Fellow Chembio Stockholders, As previously disclosed, Chembio Diagnostics, Inc. (“Chembio” or the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated as of January 31, 2023, with Biosynex SA, a F...
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, I...
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc. STRASBOURG, France, March 15, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced that Project Merci Merger Sub, Inc. (“Purchaser”), a Nevada corporation and its wholly-owned indirect subsidiary, has extended the expiration time for the previously announced tender offer to purchase all of the issued and outstanding shares of common stock (the “Shares”) of Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio”)...
Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis ...
Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt of a Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the DPP HIV-Syphilis System. “The DPP HIV-Syphilis System represents an exciting advancement in rapid testing for sexually transmitted infections. We are excited that the 200,000+ CLIA waived point-of-care tes...
Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agree...
Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement Complementary Technologies, Product Portfolios, and Market Opportunities Expected to Represent Significant Growth Drivers Consolidated Manufacturing, Sales, Marketing, Operations to Provide Synergistic Cost Savings STRASBOURG, France and HAUPPAUGE, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, and Chembio Diagnostics, Inc. (“Chembio”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focus...
Chembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis Syst...
Chembio Announces FDA CLIA Waiver Submission for DPP HIV-Syphilis System HAUPPAUGE, N.Y., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the submission to the U.S. Food and Drug Administration (FDA) for a Clinical Laboratory Improvement Amendments (CLIA) waiver for the DPP HIV-Syphilis System. “We are pleased to communicate that our DPP HIV-Syphilis System has been submitted to FDA for CLIA waiver. Upon receipt of CLIA waiver, we believe this will represent a large...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.